Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

HKG:3613 Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, HKG:3613 stock has a consensus rating of "Buy" and an average price target of $10.25. The average 1-year stock price forecast is 56.97% higher than the current stock price, while the lowest is $10.00 (+53.14%) and the highest is $10.50 (+60.80%).

Price Target: $10.25 (+56.97%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10.00	$10.25	$10.25	$10.50
Change	+53.14%	+56.97%	+56.97%	+60.80%

Analyst Ratings

The average analyst rating for HKG:3613 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '25	Aug '25	Sep '25	Dec '25	Mar '26	Jun '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst CICC No rating	CICC	Buy Maintains $10.50	Buy	Maintains	$10.50	+60.80%	Jun 19, 2026

Financial Forecast

Revenue This Year

1.67B

Increased by 10.61%

from 1.51B

Revenue Next Year

1.87B

Increased by 11.60%

from 1.67B

EPS This Year

0.53

Increased by 12.77%

from 0.47

EPS Next Year

0.59

Increased by 11.32%

from 0.53

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.56B	1.73B	1.52B	1.61B	1.51B	1.67B
Revenue Growth	18.31%	11.24%	-11.91%	5.69%	-6.10%	10.61%
Gross Profit	1.12B	1.15B	1.05B	1.07B	925.58M	1.08B
Gross Margin	71.95%	66.44%	68.67%	66.10%	61.16%	64.60%
Operating Income	772.13M	804.49M	623.91M	574.06M	476.00M	587.42M
Net Income	607.84M	645.88M	540.39M	500.28M	397.22M	495.79M
EPS	-	-	-	-	0.47	0.53
EPS Growth	-	-	-	-	-21.67%	12.77%
Forward PE	17.23	15.43	12.37	10.53	12.35	12.32
Dividend / Share	0.28	0.33	0.33	0.35	0.37	0.42
Dividend Growth	-	17.86%	-	6.06%	5.71%	13.51%
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is HKD.

Revenue Forecast

Revenue	2026	2027	2028
High	1.7B
Avg	1.7B
Low	1.7B

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.9%
Avg	10.6%
Low	10.4%

EPS Forecast

EPS	2026	2027	2028
High	0.53
Avg	0.53
Low	0.53

EPS Growth

EPS Growth	2026	2027	2028
High	12.8%
Avg	12.8%
Low	12.8%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Jun 19, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Data Sources Report a data error